ArticleBME frontiers2024
Automated HER2 Scoring in Breast Cancer Images Using Deep Learning and Pyramid Sampling.
Article in BME frontiers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Applications of Artificial Intelligence in Cancer Diagnosis and Treatment.Cancer medicine · 2026Review
- Swarm intelligence-guided ROI selection for deep learning assessment of HER2 in colorectal cancer.Scientific reports · 2026Article
- Emerging Trends in Artificial Intelligence-Integrated Biochip Technologies for Biomedical Applications.Micromachines · 2026Review
- Development of a machine learning model using structured and unstructured features for predicting surgery among patients with carpal tunnel syndrome: development and validation.Scientific reports · 2026Article
- AI-powered biomechanical modeling for ACL-reconstructed knees: predicting knee joint contact forces via computer vision and deep learning.Journal of neuroengineering and rehabilitation · 2026Article
- Urea-Formaldehyde Resin Confined Silicon Nanodots Composites: High-Performance and Ultralong Persistent Luminescence for Dynamic AI Information Encryption.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Automated HER2 Scoring with Uncertainty Quantification Using Lensfree Holography and Deep Learning.BME frontiers · 2026Article
- Automatic grading of HER2 immunohistochemical whole-slide images based on a multi-scale hierarchical graph neural network.Frontiers in public health · 2026Article
- Classification of human epidermal growth factor receptor 2 expression in cancerous breast tissue through artificial intelligenceBiomedica : revista del Instituto Nacional de Salud · 2025Article
- Article
- Transformer-BasedDiagnostics (Basel, Switzerland) · 2025Article
- BlurryScope enables compact, cost-effective scanning microscopy for HER2 scoring using deep learning on blurry images.NPJ digital medicine · 2025Article
- Simplified Artificial Intelligence Terminology for Pathologists.Diagnostics (Basel, Switzerland) · 2025Review
- [Study on lightweight plasma recognition algorithm based on depth image perception].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2025Article
- The "lows": Update on ER-low and HER2-low breast cancer.Breast (Edinburgh, Scotland) · 2024Review
- Semi-automated analysis of HER2 immunohistochemistry in invasive breast carcinoma using whole slide images: utility for interpretation in clinical practice.Pathology oncology research : POR · 2024Article
- DenseLes: slice-wise dense network for multiple sclerosis lesion segmentation and classification.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.